Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stevanato Group (STVN)
NYSE:STVN
Holding STVN?
Track your performance easily
STVN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$16.56 - $34.73
Previous CloseN/A
Volume58.94K
Average Volume (3M)370.59K
Market Cap
$6.23B
Enterprise Value$5.77B
Total Cash (Recent Filing)$126.27M
Total Debt (Recent Filing)$305.44M
Price to Earnings (P/E)49.4
Beta0.89
Next Earnings
Mar 05, 2025EPS Estimate
0.19Last Dividend Ex-Date
Jun 04, 2024Dividend Yield0.25%
Share Statistics
EPS (TTM)0.46
Shares Outstanding49,475,468
10 Day Avg. Volume307,271
30 Day Avg. Volume370,590
Standard Deviation0.12
R-Squared0.05
Alpha0.00425
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue12.04
Enterprise Value/Gross Profit16.99
Enterprise Value/Ebitda47.27
Forecast
1Y Price Target
$25.00Price Target Upside9.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Stevanato Group News
PremiumCompany Announcements
Stevanato Group Seeks New Board Member Following Unexpected Vacancy
PremiumCompany Announcements
Stevanato Group Sees Revenue Rise Amid Engineering Challenges
PremiumCompany Announcements
Stevanato Group Q3 2024 Earnings OverviewBulls Say, Bears Say
Bulls Say
Industry TrendsSTVN is positioned to benefit from strong secular tailwinds within biologics, which are driving increased demand for their High-Value Solutions offerings.
Market PositionSTVN has market leading positions in the attractive biopharmaceutical injectables end market, with a strong/broad product portfolio.
Revenue And GrowthSTVN's efforts to expand High-Value Solutions capacity should spur revenue growth and improve margins over time.
Bears Say
Cost ManagementCosts are outstripping estimates in both segments, and STVN's set-up and validation costs are running higher.
Earnings GuidanceSTVN lowered their FY24 EBITDA and EPS guide to reflect higher costs predominantly in the Engineering segment.
Financial PerformanceStevanato Group's EBITDA and EPS missed Street expectations by 8% and 4% respectively.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
STVN FAQ
What was Stevanato Group’s price range in the past 12 months?
Stevanato Group lowest stock price was $16.56 and its highest was $34.73 in the past 12 months.
What is Stevanato Group’s market cap?
Stevanato Group’s market cap is $6.23B.
When is Stevanato Group’s upcoming earnings report date?
Stevanato Group’s upcoming earnings report date is Mar 05, 2025 which is in 42 days.
How were Stevanato Group’s earnings last quarter?
Stevanato Group released its earnings results on Nov 05, 2024. The company reported $0.124 earnings per share for the quarter, missing the consensus estimate of $0.131 by -$0.007.
Is Stevanato Group overvalued?
According to Wall Street analysts Stevanato Group’s price is currently Undervalued.
Does Stevanato Group pay dividends?
Stevanato Group pays a Annually dividend of $0.057 which represents an annual dividend yield of 0.25%. See more information on Stevanato Group dividends here
What is Stevanato Group’s EPS estimate?
Stevanato Group’s EPS estimate is 0.19.
How many shares outstanding does Stevanato Group have?
Stevanato Group has 49,475,468 shares outstanding.
What happened to Stevanato Group’s price movement after its last earnings report?
Stevanato Group reported an EPS of $0.124 in its last earnings report, missing expectations of $0.131. Following the earnings report the stock price went up 16.099%.
Which hedge fund is a major shareholder of Stevanato Group?
Among the largest hedge funds holding Stevanato Group’s share is Sands Capital Management LLC. It holds Stevanato Group’s shares valued at 34M.
---
Stevanato Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.00 (9.41% Upside)
$25.00 (9.41% Upside)
Blogger Sentiment
Bullish
STVN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 94.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.54%
12-Months-Change
Fundamentals
Return on Equity
9.42%
Trailing 12-Months
Asset Growth
21.11%
Trailing 12-Months
Company Description
Stevanato Group
Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.
---
STVN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with solid growth in high-value solutions and progress in capacity expansion, but faced significant challenges such as lowered annual guidance, engineering segment difficulties, and ongoing vial destocking impacts.Read More>---
STVN Stock 12 Month Forecast
Average Price Target
$25.00
▲(9.41% Upside)
Technical Analysis
Becton Dickinson
―
Danaher
―
Thermo Fisher
―
Baxter International
―
Bio-Rad Laboratories
―
West Pharmaceutical Services
―
Best Analysts Covering STVN
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
+2.72%
reiterated a buy rating last month
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +2.72% per trade.
---